Provided by Tiger Fintech (Singapore) Pte. Ltd.

RadNet

49.44
-1.2300-2.43%
Post-market: 49.16-0.2800-0.57%19:00 EDT
Volume:812.41K
Turnover:40.15M
Market Cap:3.66B
PE:1.29K
High:50.81
Open:50.60
Low:48.46
Close:50.67
Loading ...

Company Profile

Company Name:
RadNet
Exchange:
NASDAQ
Establishment Date:
1981
Employees:
8773
Office Location:
1510 Cotner Avenue,Los Angeles,California,United States
Zip Code:
90025
Fax:
310 445 2980
Introduction:
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Directors

Name
Position
Howard G. Berger
Director,President, Chief Executive Officer and Chairman
John V. Crues, III
Director, Vice President and Medical Director
Norman R. Hames
Director, President, Chief Operating Officer-Western Operations and Secretary
David L. Swartz
Director
Lawrence L. Levitt
Director
Marvin S. Cadwell
Director
Michael L. Sherman
Director

Shareholders

Name
Position
Howard G. Berger
Director,President, Chief Executive Officer and Chairman
Norman R. Hames
Director, President, Chief Operating Officer-Western Operations and Secretary
Stephen M. Forthuber
President and Chief Operating Officer - Eastern Operations
Mark D. Stolper
Executive Vice President and Chief Financial Officer
Jeffrey L. Linden
Executive Vice President and General Counsel
John V. Crues, III
Director, Vice President and Medical Director
Michael N. Murdock
Executive Vice President and Chief Development Officer
Mital Patel
Executive Vice President of Financial Planning and Analysis